Medtronic Plc (MDT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Medtronic Plc  (NYSE: MDT)

Medtronic Plc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDT Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 64.99 % 55.69 % 71.76 % 58.89 %
Gross Margin (Q2 TTM) 47.94 % 55.86 % 68.12 % 51.79 %
Gross Profit Margin 5 Yr. Avg. 52.86 % 53.99 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 29.83 % 18.32 % 26.86 % 26.08 %
EBITDA Margin (Q2 TTM) 31.23 % 18.22 % 24.74 % 22.74 %
EBITDA Margin 5 Yr. Avg. 26.44 % 16.65 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) 18.08 % 7.64 % 24.44 % 30.23 %
Operating Margin (Q2 TTM) 18.08 % 11.26 % 21.16 % 22.52 %
Operating Margin 5 Yr. Avg. 17.43 % 10.04 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 18.13 % 10.38 % 21.91 % 17.76 %
Pre-Tax Profit Margin (Q2 TTM) 17.59 % 10.75 % 18.42 % 15.1 %
Pre-Tax Profit Margin 5 Yr. Avg. 16.64 % 8.62 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) 15.16 % 6.33 % 18.03 % 14.44 %
Net Margin (Q2 TTM) 14.03 % 8.12 % 14.93 % 12.18 %
Net Margin 5 Yr. Avg. 13.37 % 7.42 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Reportable net sales
  Explore Reportable net sales Segment  -
Cardiovascular
  Explore Cardiovascular Segment  -
Cardiovascular Cardiac Rhythm Heart Failure
  Explore Cardiovascular Cardiac Rhythm Heart Failure Segment  -
Cardiovascular Structural Heart Aortic
  Explore Cardiovascular Structural Heart Aortic Segment  -
Cardiovascular Coronary Peripheral Vascular
  Explore Cardiovascular Coronary Peripheral Vascular Segment  -
Neuroscience
  Explore Neuroscience Segment  -
Neuroscience Cranial Spinal Technologies
  Explore Neuroscience Cranial Spinal Technologies Segment  -
Neuroscience Specialty Therapies
  Explore Neuroscience Specialty Therapies Segment  -
Neuroscience Neuromodulation
  Explore Neuroscience Neuromodulation Segment  -
Medical Surgical
  Explore Medical Surgical Segment  -
Medical Surgical Surgical Endoscopy
  Explore Medical Surgical Surgical Endoscopy Segment  -
Medical Surgical Acute Care Monitoring
  Explore Medical Surgical Acute Care Monitoring Segment  -
Diabetes
  Explore Diabetes Segment  -
U S
  Explore U S Segment  -
International
  Explore International Segment  -
Reportable net sales U S
  Explore Reportable net sales U S Segment  -
Reportable net sales International
  Explore Reportable net sales International Segment  -
Cardiovascular U S
  Explore Cardiovascular U S Segment  -
Cardiovascular International
  Explore Cardiovascular International Segment  -
Neuroscience U S
  Explore Neuroscience U S Segment  -
Neuroscience International
  Explore Neuroscience International Segment  -
Medical Surgical U S
  Explore Medical Surgical U S Segment  -
Medical Surgical International
  Explore Medical Surgical International Segment  -
Diabetes U S
  Explore Diabetes U S Segment  -
Diabetes International
  Explore Diabetes International Segment  -
Other U S
  Explore Other U S Segment  -
Other International
  Explore Other International Segment  -
Ireland
  Explore Ireland Segment  -
Total other countries excluding Ireland
  Explore Total other countries excluding Ireland Segment  -
United States
  Explore United States Segment  -
Rest of world
  Explore Rest of world Segment  -
Total Reportable Segments
  Explore Total Reportable Segments Segment  -
Other segment
  Explore Other segment Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 13.22 % 2.18 % 0.23 % 0.34 %
Free Cash Flow Margin (Q2 TTM) 16.33 % 11.74 % 10.68 % 13.6 %
Free Cash Flow Margin 5 Yr. Avg. - 10.77 % 14.86 % 15.58 %
Net Cash Flow Margin (Q2 MRQ) 0 % 1.07 % 0.1 % 0.15 %
Net Cash Flow Margin (Q2 TTM) -0.34 % 2.92 % 3.9 % 10.46 %
Net Cash Flow Margin 5 Yr. Avg. - 0.81 % 3.16 % 6.44 %
Effective Tax Rate (Q2 MRQ) 16.34 % 28.5 % 17.9 % 18.8 %
Effective Tax Rate (Q2 TTM) 20.19 % 24.81 % 19.45 % 19.56 %
Effective Tax Rate 5 Yr. Avg. 19.79 % 18.87 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.